Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Circulation ; 116(16): 1821-31, 2007 Oct 16.
Article in English | MEDLINE | ID: mdl-17893272

ABSTRACT

BACKGROUND: The recent discovery that nitrite is an intrinsic vasodilator and signaling molecule at near-physiological concentrations has raised the possibility that nitrite contributes to hypoxic vasodilation and to the bioactivity of nitroglycerin and mediates the cardiovascular protective effects of nitrate in the Mediterranean diet. However, important questions of potency, kinetics, mechanism of action, and possible induction of tolerance remain unanswered. METHODS AND RESULTS: In the present study, we performed biochemical, physiological, and pharmacological studies using nitrite infusion protocols in 20 normal human volunteers and in nonhuman primates to answer these questions, and we specifically tested 3 proposed mechanisms of bioactivation: reduction to nitric oxide by xanthine oxidoreductase, nonenzymatic disproportionation, and reduction by deoxyhemoglobin. We found that (1) nitrite is a relatively potent and fast vasodilator at near-physiological concentrations; (2) nitrite functions as an endocrine reservoir of nitric oxide, producing remote vasodilation during first-pass perfusion of the opposite limb; (3) nitrite is reduced to nitric oxide by intravascular reactions with hemoglobin and with intravascular reductants (ie, ascorbate); (4) inhibition of xanthine oxidoreductase with oxypurinol does not inhibit nitrite-dependent vasodilation but potentiates it; and (5) nitrite does not induce tolerance as observed with the organic nitrates. CONCLUSIONS: We propose that nitrite functions as a physiological regulator of vascular function and endocrine nitric oxide homeostasis and suggest that it is an active metabolite of the organic nitrates that can be used therapeutically to bypass enzymatic tolerance.


Subject(s)
Drug Tolerance , Endocrine System/drug effects , Endothelium, Vascular/drug effects , Sodium Nitrite/pharmacokinetics , Vasodilator Agents/pharmacokinetics , Adult , Animals , Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Endothelium, Vascular/metabolism , Enzyme Inhibitors/administration & dosage , Female , Hemoglobins/metabolism , Humans , Infusions, Intra-Arterial , Macaca fascicularis , Male , Nitric Oxide/metabolism , Oxidation-Reduction , Oxypurinol/administration & dosage , Regional Blood Flow/drug effects , Sodium Nitrite/administration & dosage , Sodium Nitrite/blood , Vasodilation/drug effects , Vasodilator Agents/administration & dosage , Vasodilator Agents/blood , Xanthine Oxidase/metabolism
2.
Free Radic Biol Med ; 41(4): 541-8, 2006 Aug 15.
Article in English | MEDLINE | ID: mdl-16863986

ABSTRACT

There are a number of difficulties involved in the quantification of nitrite in biological systems. These difficulties result from oxidation of nitrite (within minutes) by heme proteins, such as hemoglobin, myoglobin, cytoglobin, and neuroglobin; its low levels in vivo; and its ubiquitous presence in laboratory buffers and glassware. The goal of this review is to present an assay suitable for the sensitive and specific measurement of intravascular nitrite in mammals using the chemiluminescence-based nitric oxide analyzer and to inform the reader on how to evade the pitfalls pertinent to nitrite determination in biological matrices.


Subject(s)
Nitrites/blood , Animals , Data Interpretation, Statistical , Humans , Luminescence
3.
Blood ; 106(2): 734-9, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15774613

ABSTRACT

Plasma levels of nitrite ions have been used as an index of nitric oxide synthase (NOS) activity in vivo. Recent data suggest that nitrite is a potential intravascular repository for nitric oxide (NO), bioactivated by a nitrite reductase activity of deoxyhemoglobin. The precise levels and compartmentalization of nitrite within blood and erythrocytes have not been determined. Nitrite levels in whole blood and erythrocytes were determined using reductive chemiluminescence in conjunction with a ferricyanide-based hemoglobin oxidation assay to prevent nitrite destruction. This method yields sensitive and linear measurements of whole blood nitrite over 24 hours at room temperature. Nitrite levels measured in plasma, erythrocytes, and whole blood from 15 healthy volunteers were 121 plus or minus 9, 288 plus or minus 47, and 176 plus or minus 17 nM, indicating a surprisingly high concentration of nitrite within erythrocytes. The majority of nitrite in erythrocytes is located in the cytosol unbound to proteins. In humans, we found a significant artery-to-vein gradient of nitrite in whole blood and erythrocytes. Shear stress and acetylcholine-mediated stimulation of endothelial NOS significantly increased venous nitrite levels. These studies suggest a dynamic intravascular NO metabolism in which endothelial NOS-derived NO is stabilized as nitrite, transported by erythrocytes, and consumed during arterial-to-venous transit.


Subject(s)
Erythrocytes/metabolism , Nitrites/blood , Adult , Endothelium, Vascular/metabolism , Female , Ferricyanides , Hemoglobins/metabolism , Humans , In Vitro Techniques , Male , Models, Biological , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type III , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL
...